{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:56Z","timestamp":1791644696539,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1084-0","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T14:03:13Z","timestamp":1560780193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry"],"prefix":"10.1186","volume":"20","author":[{"name":"on behalf of the SEPAR-IPF National Registry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrella","family":"Fern\u00e1ndez-Fabrellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-1723","authenticated-orcid":false,"given":"Mar\u00eda","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio Rodr\u00edguez","family":"Portal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ancochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Xaubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","volume":"142","author":"FJ Martinez","year":"2005","unstructured":"Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142:963\u20137.","journal-title":"Ann Intern Med"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389:1941\u201352.","journal-title":"Lancet."},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19:32.","journal-title":"Respir Res"},{"key":"1084_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/CLEP.S54815","volume":"5","author":"B Ley","year":"2013","unstructured":"Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;5:483\u201392.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"1084_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"Brett Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431\u2013440.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1378\/chest.111.1.51","volume":"111","author":"R Erbes","year":"1997","unstructured":"Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest. 1997;111:51\u20137.","journal-title":"Chest"},{"key":"1084_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/ajrccm.164.7.2003140","volume":"164","author":"TE King Jr","year":"2001","unstructured":"King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis. Scoring system and survival model. Am J Respir Crit Care Med. 2001;164:1171\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1378\/chest.06-2784","volume":"131","author":"M Alakhras","year":"2007","unstructured":"Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007;131:1448\u201353.","journal-title":"Chest"},{"key":"1084_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.200611-1696OC","volume":"177","author":"H Sumikawa","year":"2008","unstructured":"Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177:433\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR11","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers J, Richeldi L, Ryerson C, Lederer D, Behr J, Cottin V, Danoff S, Morell F, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018;6:138\u201353.","journal-title":"Lancet Respir Med"},{"key":"1084_CR13","unstructured":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). The voice of the patient: a series of reports from the U.S. Food and Drug Administration's (FDA's) patient-focused drug development initiative. [Accessed 03 June 2018]. Available from URL: \n                    http:\/\/www.fda.gov\/downloads\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/UCM440829.pdf\n                    \n                  ."},{"key":"1084_CR14","unstructured":"European Medicines Agency. Esbriet (Pirfenidone). CHMP assessment report. [Accessed 03 June 2018]. Available from URL: \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002154\/WC500103073.pdf\n                    \n                  ."},{"key":"1084_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1183\/09059180.00002113","volume":"22","author":"KM Antoniou","year":"2013","unstructured":"Antoniou KM, Margaritopoulos GA, Siafakas NM. Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future. Eur Respir Rev. 2013;22:281\u201391.","journal-title":"Eur Respir Rev"},{"key":"1084_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1183\/09031936.00073012","volume":"41","author":"WA Wuyts","year":"2013","unstructured":"Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, Cottin V, Egan JJ, Lambrecht BN, Lories R, Parfrey H, et al. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. 2013;41:1207\u201318.","journal-title":"Eur Respir J"},{"key":"1084_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1183\/09031936.00027913","volume":"42","author":"JF Cordier","year":"2013","unstructured":"Cordier JF, Cottin V. Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis. Eur Respir J. 2013;42:916\u201323.","journal-title":"Eur Respir J"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/09031936.00217614","volume":"46","author":"J Behr","year":"2015","unstructured":"Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Groh\u00e9 C, Wilkens H, et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J. 2015;46:186\u201396.","journal-title":"Eur Respir J"},{"key":"1084_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12890-015-0074-3","volume":"15","author":"J Kaunisto","year":"2015","unstructured":"Kaunisto J, Kelloniemi K, Sutinen E, Hodgson U, Piilonen A, Kaarteenaho R, M\u00e4kitaro R, Purokivi M, Lappi-Blanco E, Saarelainen S, et al. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis. BMC Pulm Med. 2015;15:92.","journal-title":"BMC Pulm Med"},{"key":"1084_CR20","doi-asserted-by":"publisher","first-page":"31090","DOI":"10.3402\/ecrj.v3.31090","volume":"3","author":"G Ferrara","year":"2016","unstructured":"Ferrara G, Carlson L, Palm A, Einarsson J, Olivesten C, Sk\u00f6ld M. Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-registry. Eur Clin Respir J. 2016;3:31090.","journal-title":"Eur Clin Respir J"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1164\/rccm.201607-1484OC","volume":"195","author":"S Singh","year":"2017","unstructured":"Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, Singh N, Ho L, Samaria JK, Bhattacharya P, et al. Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med. 2017;195:801\u201313.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1084_CR22","doi-asserted-by":"publisher","first-page":"1601592","DOI":"10.1183\/13993003.01592-2016","volume":"49","author":"Helen E. Jo","year":"2017","unstructured":"Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PM, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, et al. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian idiopathic pulmonary fibrosis registry. Eur Respir J. 2017;49(2). \n                    https:\/\/doi.org\/10.1183\/13993003.01592-2016\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"1084_CR23","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/crj.12700","volume":"12","author":"M Doubkov\u00e1","year":"2018","unstructured":"Doubkov\u00e1 M, \u0160vancara J, Svoboda M, \u0160terclov\u00e1 M, Barto\u0161 V, Pla\u010dkov\u00e1 M, Lacina L, \u017durkov\u00e1 M, Binkov\u00e1 I, Bittenglov\u00e1 R, et al. EMPIRE registry, Czech part: impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis. Clin Respir J. 2018;12:1526\u201335.","journal-title":"Clin Respir J"},{"key":"1084_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12931-018-0845-5","volume":"19","author":"A Guenther","year":"2018","unstructured":"Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, et al. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19:141.","journal-title":"Respir Res"},{"key":"1084_CR25","unstructured":"STrengthening the reporting of OBservational studies in epidemiology (STROBE) guidance for reporting observational research. [Accessed 03 June 2018]. Available from URL: \n                    http:\/\/strobe-statement.org\/index.php?id=strobe-home\n                    \n                  ."},{"key":"1084_CR26","unstructured":"SEPAR Website. [accessed 03 June 2018]. Available from URL: \n                    https:\/\/www.separ.es\/?q=node\/233\n                    \n                  ."},{"key":"1084_CR27","unstructured":"Spanish Society of Pneumology and Thoracic Surgery (SEPAR). [Unidades acreditadas de enfermedades pulmonares intersticiales difusas]. [Accessed 03 June 2018]. Available from URL: \n                    https:\/\/www.separ.es\/?q=node\/826\n                    \n                  ."},{"key":"1084_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1183\/09031936.00051914","volume":"44","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Corte TJ, Collard HR, Richeldi L. A global registry for idiopathic pulmonary fibrosis: the time is now. Eur Respir J. 2014;44:273\u20136.","journal-title":"Eur Respir J"},{"key":"1084_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.arbres.2013.03.011","volume":"49","author":"A Xaubet","year":"2013","unstructured":"Xaubet A, Ancochea J, Bollo E, Fern\u00e1ndez-Fabrellas E, Franquet T, Molina-Molina M, Montero MA, Serrano-Mollar A. Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) research group on diffuse pulmonary diseases. Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) research group on diffuse pulmonary diseases. Arch Bronconeumol. 2013;49:343\u201353.","journal-title":"Arch Bronconeumol"},{"key":"1084_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S2213-2600(14)70011-6","volume":"2","author":"G Raghu","year":"2014","unstructured":"Raghu G, Lynch D, Godwin JD, Webb R, Colby TV, Leslie KO, Behr J, Brown KK, Egan JJ, Flaherty KR, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir Med. 2014;2:277\u201384.","journal-title":"Lancet Respir Med"},{"key":"1084_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1378\/chest.14-0976","volume":"147","author":"JH Chung","year":"2015","unstructured":"Chung JH, Chawla A, Peljto AL, Cool CD, Groshong SD, Talbert JL, McKean DF, Brown KK, Fingerlin TE, Schwarz MI, et al. CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest. 2015;147:450\u20139.","journal-title":"Chest"},{"issue":"2","key":"1084_CR32","doi-asserted-by":"publisher","first-page":"1700936","DOI":"10.1183\/13993003.00936-2017","volume":"50","author":"Simon L.F. Walsh","year":"2017","unstructured":"Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J. 2017;50(2). \n                    https:\/\/doi.org\/10.1183\/13993003.00936-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"1084_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000436980","volume":"90","author":"KM Antoniou","year":"2015","unstructured":"Antoniou KM, Symvoulakis EK, Anyfantakis D, Wells AU. New treatments for idiopathic pulmonary fibrosis: \u2018die another day\u2019 if diagnosed early? Respiration. 2015;90:352.","journal-title":"Respiration."},{"key":"1084_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12890-017-0468-5","volume":"17","author":"TM Maher","year":"2017","unstructured":"Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries. BMC Pulm Med. 2017;17:124.","journal-title":"BMC Pulm Med"},{"issue":"145","key":"1084_CR35","doi-asserted-by":"publisher","first-page":"170053","DOI":"10.1183\/16000617.0053-2017","volume":"26","author":"Sebastiano Emanuele Torrisi","year":"2017","unstructured":"Torrisi SE, Pavone M, Vancheri A, Vancheri C. When to start and when to stop antifibrotic therapies. Eur Respir Rev. 2017;26(145). \n                    https:\/\/doi.org\/10.1183\/16000617.0053-2017\n                    \n                  .","journal-title":"European Respiratory Review"},{"key":"1084_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000490667","volume":"96","author":"TM Maher","year":"2018","unstructured":"Maher TM, Swigris JJ, Kreuter M, Wijsenbeek M, Cassidy N, Ireland L, Axmann J, Nathan SD. Identifying barriers to idiopathic pulmonary fibrosis treatment: a survey of patient and physician views. Respiration. 2018;96:514\u201324.","journal-title":"Respiration."},{"key":"1084_CR37","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46:1113\u201330.","journal-title":"Eur Respir J"},{"key":"1084_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1183\/09031936.06.00037005","volume":"27","author":"G Raghu","year":"2006","unstructured":"Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136\u201342.","journal-title":"Eur Respir J"},{"key":"1084_CR39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","volume":"104","author":"SD Nathan","year":"2010","unstructured":"Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med. 2010;104:1035\u201341.","journal-title":"Respir Med"},{"key":"1084_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","volume":"1","author":"JS Lee","year":"2013","unstructured":"Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G, Investigators IPF. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1:369\u201376.","journal-title":"Lancet Respir Med"},{"key":"1084_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","volume":"4","author":"M Kreuter","year":"2016","unstructured":"Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJ, et al. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016;4:381\u20139.","journal-title":"Lancet Respir Med"},{"key":"1084_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/thoraxjnl-2011-200836","volume":"67","author":"CM Barber","year":"2012","unstructured":"Barber CM, Fishwick D. Importance of past occupational exposures in the rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2012;67:264\u20135.","journal-title":"Thorax"},{"key":"1084_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12890-018-0644-2","volume":"18","author":"G Paolocci","year":"2018","unstructured":"Paolocci G, Folletti I, Tor\u00e9n K, Ekstr\u00f6m M, Dell'Omo M, Muzi G, Murgia N. Occupational risk factors for idiopathic pulmonary fibrosis in southern Europe: a case-control study. BMC Pulm Med. 2018;18:75.","journal-title":"BMC Pulm Med"},{"key":"1084_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/thoraxjnl-2015-207011","volume":"71","author":"SD Nathan","year":"2016","unstructured":"Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, et al. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016;71:429\u201335.","journal-title":"Thorax"},{"key":"1084_CR45","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","volume":"377","author":"PW Noble","year":"2011","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011;377:1760\u20139.","journal-title":"Lancet"},{"key":"1084_CR46","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"1084_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2015.02.002","volume":"109","author":"Hyun Joo Kim","year":"2015","unstructured":"Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis. Respir Med. 2015;109(6):661-70.","journal-title":"Respiratory Medicine"},{"key":"1084_CR48","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","volume":"184","author":"RM du Bois","year":"2011","unstructured":"du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE Jr, Lancaster L, Noble PW, Sahn SA, et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011;184:1382\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR49","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167:962\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1084_CR50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684\u201391.","journal-title":"Ann Intern Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1084-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:20:04Z","timestamp":1592263204000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1084-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1084-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"7 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each participating hospital obtained the ethic approval from the Human Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EF-F received funding for research grants and advisory boards from Hoffman-La Roche, Boeringher Ing., GSK, Chiesi, Esteve Teijin Healthcare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}